Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cavassini

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
HIV Medicine|May 23, 2009
How reliable is an undetectable viral load?Christophe Combescure, N Vallier, B Ledergerber, et al.
HIV Medicine|June 4, 2009
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort StudyR Weber, M Huber, M Rickenbach, et al.
HIV Medicine|May 10, 2014
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort StudyJ Schäfer, J Young, E Bernasconi, et al.
Infection|September 4, 2010
Periurethral abscess complicating gonococcal urethritis: case report and literature reviewA Kenfak-Foguena, Y Zarkik, M Wisard, et al.
HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2006
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapyS Bertschy, M Opravil, M Cavassini, et al.
Journal of Internal Medicine|February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapyJ A C Sterne, M May, H C Bucher, et al.
HIV Medicine|April 21, 2021
Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort StudyH Kovari, B Surial, P E Tarr, et al.
International Journal of STD & AIDS|July 4, 2017
A prospective multicentre study of healthcare provider preference in rapid HIV testing kits: Determine versus INSTIN Amyai, Kea Darling, V D'Acremont, et al.
HIV Medicine|September 18, 2008
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort StudyC Bellini, O Keiser, J-P Chave, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
HIV Medicine|May 23, 2009
How reliable is an undetectable viral load?Christophe Combescure, N Vallier, B Ledergerber, et al.
HIV Medicine|June 4, 2009
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort StudyR Weber, M Huber, M Rickenbach, et al.
HIV Medicine|May 10, 2014
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort StudyJ Schäfer, J Young, E Bernasconi, et al.
Infection|September 4, 2010
Periurethral abscess complicating gonococcal urethritis: case report and literature reviewA Kenfak-Foguena, Y Zarkik, M Wisard, et al.
HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 16, 2006
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapyS Bertschy, M Opravil, M Cavassini, et al.
Journal of Internal Medicine|February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapyJ A C Sterne, M May, H C Bucher, et al.
HIV Medicine|April 21, 2021
Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort StudyH Kovari, B Surial, P E Tarr, et al.
International Journal of STD & AIDS|July 4, 2017
A prospective multicentre study of healthcare provider preference in rapid HIV testing kits: Determine versus INSTIN Amyai, Kea Darling, V D'Acremont, et al.
HIV Medicine|September 18, 2008
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort StudyC Bellini, O Keiser, J-P Chave, et al.
Pageof 8